Nozomi Furuzono
Papers
7
Total Citations
35
H-Index
4
About
Nozomi Furuzono is an emerging gynecologic surgeon and researcher whose work sits at the forefront of minimally invasive and robotic-assisted surgery for gynecologic disorders. Based in Japan, Furuzono has established a focused research program examining the comparative safety, efficacy, and outcomes of advanced surgical platforms — most notably the da Vinci® Xi and the domestically developed hinotori™ Surgical Robot System — across a range of conditions including endometrial cancer, cervical cancer, and pelvic organ prolapse. Among Furuzono's most significant contributions are rigorous retrospective analyses involving hundreds of patients that have helped validate the hinotori™ system as a clinically viable alternative to the globally dominant da Vinci® platform, work that carries particular importance for Japanese healthcare adoption of home-grown surgical technologies. Furuzono has also advanced the evidence base for sentinel lymph node navigation surgery in early-stage cervical and endometrial cancers, addressing critical gaps in long-term recurrence data. Additional research exploring automated performance metrics and the impact of obesity on surgical outcomes reflects a broader commitment to surgical quality improvement and population-specific care. With a growing publication record accumulating over 35 citations in 2024–2025 alone, Furuzono represents a promising voice in gynecologic oncology and robotic surgery research.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7